Towle & Co. Invests $3.19 Million in Oscar Health, Inc. $OSCR

Towle & Co. acquired a new stake in Oscar Health, Inc. (NYSE:OSCR) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 278,489 shares of the company’s stock, valued at approximately $3,194,000.

Other large investors also recently modified their holdings of the company. Strs Ohio acquired a new position in Oscar Health in the first quarter valued at $30,000. Jones Financial Companies Lllp grew its holdings in Oscar Health by 7,473.3% during the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after acquiring an additional 2,242 shares during the period. Quarry LP grew its holdings in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after acquiring an additional 1,469 shares during the period. Fifth Third Bancorp grew its holdings in Oscar Health by 148.7% during the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after acquiring an additional 1,413 shares during the period. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of Oscar Health in the 1st quarter worth about $49,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 6th. Weiss Ratings raised Oscar Health from a “sell (d)” rating to a “sell (d+)” rating in a research note on Friday, July 10th. Wolfe Research began coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They set a “peer perform” rating for the company. Wells Fargo & Company set a $20.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Thursday, June 4th. Finally, UBS Group raised their price target on shares of Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $20.78.

Oscar Health Trading Down 1.8%

NYSE OSCR opened at $28.97 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $33.10. The business has a 50 day moving average price of $27.45 and a 200-day moving average price of $19.41. The company has a market cap of $8.74 billion, a price-to-earnings ratio of -49.11, a P/E/G ratio of 1.65 and a beta of 2.34.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The company had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. During the same period last year, the business earned $0.92 EPS. Oscar Health’s quarterly revenue was up 52.6% compared to the same quarter last year. As a group, equities analysts expect that Oscar Health, Inc. will post 0.59 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Janet Liang sold 12,475 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $273,701.50. Following the transaction, the insider owned 259,057 shares in the company, valued at approximately $5,683,710.58. This represents a 4.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Richard Scott Blackley sold 31,683 shares of Oscar Health stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total transaction of $695,125.02. Following the transaction, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at $23,584,995.38. This represents a 2.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 3,662,466 shares of company stock worth $105,145,815 in the last ninety days. 22.64% of the stock is currently owned by corporate insiders.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.